A Study of HR+/HER2- Metastatic Breast Cancer Patients Treated With Palbociclib Together With an Aromatase Inhibitor From 2017 to 2023 in Denmark.

NCT06307457 · clinicaltrials.gov ↗
COMPLETED
Status
604
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer